Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shankar Thangamani

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Frontiers in Microbiology|August 19, 2015
Repurposing celecoxib as a topical antimicrobial agentShankar Thangamani, Waleed Younis, Mohamed N Seleem
Plos One|July 30, 2015
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant PathogensShankar Thangamani, Waleed Younis, Mohamed N Seleem
Current Pharmaceutical Design|March 12, 2015
Antimicrobial peptides and peptidomimetics - potent therapeutic allies for staphylococcal infectionsHaroon Mohammad, Shankar Thangamani, Mohamed N Seleem
Microbiology Spectrum|June 24, 2024
Intradermal infection and dissemination of <i>Candida auris</i> in immunocompetent and immunocompromised mouse modelsKristine A Towns, Abhishek Datta, Shankar Thangamani
Plos Pathogens|October 19, 2023
Tools and techniques to identify, study, and control Candida aurisJames Carty, Anuradha Chowdhary, Douglas Bernstein, et al.
The Journal of Infectious Diseases|June 5, 2025
Deletion of Galectin-3 Renders Mice Less Susceptible to Candida auris Skin Infection by Enhancing Antifungal Activity of NeutrophilsShrihari M Ganesh, Michail S Lionakis, Shankar Thangamani
Organic & Biomolecular Chemistry|May 1, 2015
Targeting intracellular bacteria with an extended cationic amphiphilic polyproline helixManish Nepal, Shankar Thangamani, Mohamed N Seleem, et al.
Drug Design, Development and Therapy|November 7, 2015
Antibacterial activity and therapeutic efficacy of Fl-P(R)P(R)P(L)-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infectionShankar Thangamani, Manish Nepal, Jean Chmielewski, et al.
Current Pharmaceutical Design|March 12, 2015
Drug repurposing for the treatment of staphylococcal infectionsShankar Thangamani, Haroon Mohammad, Waleed Younis, et al.
Msphere|June 21, 2024
Yeast and filamentous <i>Candida auris</i> stimulate distinct immune responses in the skinGarrett Bryak, Abigail Cox, Michail S Lionakis, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Microbiology|August 19, 2015
Repurposing celecoxib as a topical antimicrobial agentShankar Thangamani, Waleed Younis, Mohamed N Seleem
Plos One|July 30, 2015
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant PathogensShankar Thangamani, Waleed Younis, Mohamed N Seleem
Current Pharmaceutical Design|March 12, 2015
Antimicrobial peptides and peptidomimetics - potent therapeutic allies for staphylococcal infectionsHaroon Mohammad, Shankar Thangamani, Mohamed N Seleem
Microbiology Spectrum|June 24, 2024
Intradermal infection and dissemination of <i>Candida auris</i> in immunocompetent and immunocompromised mouse modelsKristine A Towns, Abhishek Datta, Shankar Thangamani
Plos Pathogens|October 19, 2023
Tools and techniques to identify, study, and control Candida aurisJames Carty, Anuradha Chowdhary, Douglas Bernstein, et al.
The Journal of Infectious Diseases|June 5, 2025
Deletion of Galectin-3 Renders Mice Less Susceptible to Candida auris Skin Infection by Enhancing Antifungal Activity of NeutrophilsShrihari M Ganesh, Michail S Lionakis, Shankar Thangamani
Organic & Biomolecular Chemistry|May 1, 2015
Targeting intracellular bacteria with an extended cationic amphiphilic polyproline helixManish Nepal, Shankar Thangamani, Mohamed N Seleem, et al.
Drug Design, Development and Therapy|November 7, 2015
Antibacterial activity and therapeutic efficacy of Fl-P(R)P(R)P(L)-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infectionShankar Thangamani, Manish Nepal, Jean Chmielewski, et al.
Current Pharmaceutical Design|March 12, 2015
Drug repurposing for the treatment of staphylococcal infectionsShankar Thangamani, Haroon Mohammad, Waleed Younis, et al.
Msphere|June 21, 2024
Yeast and filamentous <i>Candida auris</i> stimulate distinct immune responses in the skinGarrett Bryak, Abigail Cox, Michail S Lionakis, et al.
Pageof 6